Leveraging Cisplatin-Derived Prodrugs as Helper Lipids in LNPs to Boost the Efficacy of Cancer Chemoimmunotherapy

Journal:

ACS Nano

Published:

2025-12-22

DOI:

10.1021/acsnano.5c18243

Affiliations:

14

Authors:

14

Go to article

Institutions	Authors	Share
Dongguan People's Hospital, China	6.000000	0.43
National University of Singapore (NUS), Singapore	4.750000	0.34
The Second Affiliated Hospital, Guangxi Medical University, China	1.500000	0.11
LuoHu Affiliated Hospital of Shenzhen University, China	1.000000	0.07
Hainan Medical University, China	0.500000	0.04
Clinical Imaging Research Centre (CIRC), Singapore	0.125000	0.01
Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore	0.125000	0.01

Interested in Pharmacology and Pharmaceutical Sciences?